APA (7th ed.) Citation

A, S., M, P., T, M., T, P., KA, K., H, M., . . . S, S. (2021). Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany. Epilepsia, 62(10), 2518. https://doi.org/10.1111/epi.17034

Chicago Style (17th ed.) Citation

A, Strzelczyk, et al. "Efficacy, Tolerability, and Retention of Fenfluramine for the Treatment of Seizures in Patients with Dravet Syndrome: Compassionate Use Program in Germany." Epilepsia 62, no. 10 (2021): 2518. https://doi.org/10.1111/epi.17034.

MLA (9th ed.) Citation

A, Strzelczyk, et al. "Efficacy, Tolerability, and Retention of Fenfluramine for the Treatment of Seizures in Patients with Dravet Syndrome: Compassionate Use Program in Germany." Epilepsia, vol. 62, no. 10, 2021, p. 2518, https://doi.org/10.1111/epi.17034.